Definium Therapeutics, Inc. · NASDAQ:DFTX

Wiley Matthew T. received 62,500 Definium Therapeutics, Inc. shares as an award (Form 4)

Traded Jun 22, 2026 · Filed Jun 22, 2026

On Jun 22, 2026, Wiley Matthew T. (Chief Commercial Officer) received 62,500 Definium Therapeutics, Inc. shares as an award, leaving 177,500 shares. Filed Jun 22, 2026 (Form 4).

Awarded
62,500 shares
Holding after
177,500 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common SharesAward62,500177,500Direct

Source

View original at SEC

Related